The new option for high risk patients is the Transcatheter Aortic Valve Replacement (TAVR). The procedure gives Deborah’s surgical and interventional teams a sophisticated, minimally invasive catheter-based treatment option for repairing stenotic aortic valves—without traditional open-heart surgery.
Conducted within the Hybrid Operating Room, this approach is a viable option for patients considered too high-risk for an open-heart procedure. TAVR represents a new standard in the quality of patient care.
The Facts About Aortic Valve Disease:
- The cause of 25,000 deaths each year
- 7% of the population of the age of 65 is affected
- 2 years after the diagnosis of severe aortic stenosis, patients have a survival rate as high as 50%